Repository logo
 

Large-scale exome sequence analysis identifies sex- and age-specific determinants of obesity.

Accepted version
Peer-reviewed

No Thumbnail Available

Type

Article

Change log

Authors

Kentistou, Katherine A 
Stankovic, Stasa 
Gardner, Eugene J 
Day, Felix R 

Abstract

Obesity contributes substantially to the global burden of disease and has a significant heritable component. Recent large-scale exome sequencing studies identified several genes in which rare, protein-coding variants have large effects on adult body mass index (BMI). Here we extended such work by performing sex-stratified associations in the UK Biobank study (N∼420,000). We identified genes in which rare heterozygous loss-of-function increases adult BMI in women (DIDO1, PTPRG, and SLC12A5) and in men (SLTM), with effect sizes up to ∼8 kg/m2. This is complemented by analyses implicating rare variants in OBSCN and MADD for recalled childhood adiposity. The known functions of these genes, as well as findings of common variant genome-wide pathway enrichment analyses, suggest a role for neuron death, apoptosis, and DNA damage response mechanisms in the susceptibility to obesity across the life-course. These findings highlight the importance of considering sex-specific and life-course effects in the genetic regulation of obesity.

Description

Keywords

DNA damage, GWAS, UK Biobank, exome-wide association study, obesity, rare variant, type 2 diabetes

Journal Title

Cell Genom

Conference Name

Journal ISSN

2666-979X
2666-979X

Volume Title

Publisher

Elsevier BV
Sponsorship
Medical Research Council (MC_UU_12015/2)
MRC (MC_UU_00006/2)
MRC (MC_UU_00014/4)
Cancer Research UK (DRCPGM\100005)
European Commission Horizon 2020 (H2020) ERC (855741)
Wellcome Trust (206388/Z/17/Z)
Cancer Research UK (18796)
Cancer Research UK (C6946/A24843)
Cancer Research UK (C17918/A28870)
Wellcome Trust (203144/A/16/Z)
Medical Research Council (MC_PC_12012)
British Heart Foundation (RG/17/12/33167)
MRC (MC_UU_00014/1)
MRC (MC_UU_00014/5)
This work was funded by the Medical Research Council (Unit programs: MC_UU_12015/2, MC_UU_00006/2, MC_UU_00014/4). LD is a Royal Society Dorothy Hodgkin Fellow. Research in the SPJ lab is funded by Cancer Research UK Discovery Grant (DRCPGM\100005), CRUK RadNet Cambridge (C17918/A28870), ERC Synergy grant DDREAMM (855741) and core funding provided by CRUK Cambridge Institute (A:29580). This project has received funding from CRUK DRCPGM\100005 and C6/A18796 (CC and FP) and Wellcome Investigator Award 206388/Z/17/Z (GZV). Gurdon Institute core infrastructure funding was provided by Cancer Research UK (C6946/A24843) and Wellcome (WT203144).